Clinical Trials Directory

Trials / Completed

CompletedNCT00227838

Modifying Group Therapy for Bipolar Substance Abusers - 1

Modifying Group Therapy for Bipolar Abusers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 sessions in this trial, and is being conducted by front-line drug counselors, to test its effectiveness in a more community-based setting. The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT.

Detailed description

IGT is being compared with 12 sessions of Group Drug Counseling (GDC) in a randomized controlled trial, with a sample size of 60 subjects. GDC is the type of treatment one would likely receive in a community drug abuse treatment program, in that it focuses primarily in substance use, unlike IGT, which focuses equally on SUD and BD issues. Patients are followed for a year after the end of the group therapy, to examine the long-term effects of the treatment, and also to examine the longer-term relationship of substance use and mood. Patients in the trial must be taking a mood stabilizer to enter the study. Any drug of abuse is accepted, and all subtypes of BD are accepted.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavior Therapy

Timeline

Start date
2003-07-01
Primary completion
2005-06-01
Completion
2005-08-01
First posted
2005-09-28
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00227838. Inclusion in this directory is not an endorsement.